Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06763172
PHASE4

Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI

Sponsor: Hsiao-Ying Wey

View on ClinicalTrials.gov

Summary

This research study aims to determine whether and how caffeine intake affects learning process through reward feedback compared to placebo. The data acquired from this study would improve our understanding on the consequence and mechanism of caffeine intake in the aspect of learning process. Participants will perform a reinforcement learning task (i.e. Probabilistic Selection Task) and a motor inhibition task (i.e. Go/NoGo task) in a brain scan. The scan will be done with the Siemens Biograph mMR positron emission tomography (PET)/ magnetic resonance imaging (MRI) 3 Tesla scanner. The PET allows us to see the changes in the "reward signals" - dopamine - in the brain using a radioactive dye called \[11C\]Raclopride. The MRI, on the other hand, enables us to take detailed pictures of the brain activities during cognitive tasks using a high-powered magnet. Reviewing these pictures will help us understand the influence of caffeine on reward signals and brain activities during the learning process.

Official title: Measure Striatal Adenosine-dopamine Receptors Interactions: from Molecule to Behaviors

Key Details

Gender

All

Age Range

18 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2023-05-17

Completion Date

2026-12-31

Last Updated

2025-01-09

Healthy Volunteers

Yes

Interventions

DRUG

Caffeine (200 mg)

Caffeine (200mg) will be administered per os 20 minutes prior to the PET/fMRI data acquisition.

DRUG

Placebo

Lactose tablet will be administered per os 20 minutes prior to the PET/fMRI data acquisition.

Locations (1)

Athinoula A. Martinos Center for Biomedical Imaging

Charlestown, Massachusetts, United States